Atypical femur fracture in a male without history of bisphosphonate use: a case report

被引:0
|
作者
Al-Ajlouni, Yazan A. [1 ]
Lee, Justin Lin [1 ]
Lee, Jessica Lin [1 ]
Samuels, Blossom [1 ,2 ]
机构
[1] New York Med Coll, Sch Med, Valhalla, NY 10595 USA
[2] Westchester Med Ctr, Valhalla, NY 10595 USA
关键词
Atypical femur fractures; Bisphosphonate-naive; Male; Teriparatide; Surgical management; FEMORAL FRACTURES; TERIPARATIDE; RISK;
D O I
10.1186/s13256-023-04308-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundAtypical femur fractures are a rare occurrence, especially in bisphosphonate-naive men, and merit reporting owing to their unusual presentation and clinical implications. This case report highlights a unique instance of atypical femur fractures in a 73-year-old male with no prior bisphosphonate exposure.Case presentationThe patient, a 73-year-old Indian male with no history of bisphosphonate use, presented with left thigh pain and swelling following a minor fall. Radiographic assessment unveiled a closed left mid diaphyseal femoral shaft fracture. Subsequent imaging revealed an impending fracture in the contralateral femur. A comprehensive diagnostic evaluation, encompassing radiographic analysis, laboratory tests, and clinical assessment confirmed the diagnosis. Surgical management via intramedullary nailing was pursued for both fractures. Notably, the patient's medical history was characterized by radiographic manifestations, the infrequent occurrence of atypical femur fractures in men, and associated risk factors. Treatment encompassed anabolic bone therapy employing teriparatide, alongside discontinuation of antiresorptive agents.ConclusionsThis case underscores the significance of considering atypical femur fractures in older individuals with limited trauma history. It accentuates the role of anabolic agents in the therapeutic regimen and contributes to the evolving understanding of atypical femur fractures. The report underscores the need for vigilant monitoring and tailored management strategies in similar cases, thereby enhancing clinical practice and patient care.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Atypical femoral fracture in a beta-thalassemia major patient with previous bisphosphonate use: case report and a review of the literature
    Lampropoulou-Adamidou, K.
    Tournis, S.
    Triantafyllopoulos, I. K.
    JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS, 2016, 16 (01) : 75 - 78
  • [42] A CASE REPORT OF A STRANGE FEMORAL SHAFT TRANSVERSE FRACTURE WITH BISPHOSPHONATE USE
    Hiroyuki, O.
    Kousei, Y.
    Akira, O.
    Hiroshi, T.
    Syunichiro, K.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : S749 - S749
  • [43] Validated bisphosphonate exposure in patients with Atypical Femur Fracture in two large international cohorts
    Adams, Annette L.
    Gilfillan, Alec
    Ryan, Denison
    Sand, Rickard
    Bogl, Hans Peter
    Wezenberg, Daphne
    Black, Dennis M.
    Bauer, Douglas C.
    Thompson, Austin R.
    Lyth, Johan
    Schilcher, Jorg
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 : 306 - 306
  • [44] Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years
    Joan C. Lo
    Romain S. Neugebauer
    Bruce Ettinger
    Malini Chandra
    Rita L. Hui
    Susan M. Ott
    Christopher D. Grimsrud
    Monika A. Izano
    BMC Musculoskeletal Disorders, 21
  • [45] Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years
    Lo, Joan C.
    Neugebauer, Romain S.
    Ettinger, Bruce
    Chandra, Malini
    Hui, Rita L.
    Ott, Susan M.
    Grimsrud, Christopher D.
    Izano, Monika A.
    BMC MUSCULOSKELETAL DISORDERS, 2020, 21 (01)
  • [46] Bone Structure and Turnover Status in Women with and without Atypical Femur Fracture Following Long-term Bisphosphonate Therapy.
    Dhaliwal, Ruban
    Qiu, Shijing
    Warner, Elizabeth
    Cibula, Donald
    Rao, Sudhaker D.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S295 - S295
  • [47] In women, bisphosphonate use for ≥3 years vs. <3 months was linked to increased atypical femur fracture risk
    Ott, Susan M.
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (01) : JC9 - JC9
  • [48] Risk of atypical femoral fracture during and after bisphosphonate use Full report of a nationwide study
    Schilcher, Jorg
    Koeppen, Veronika
    Aspenberg, Per
    Michaelsson, Karl
    ACTA ORTHOPAEDICA, 2015, 86 (01) : 100 - 107
  • [49] Atypical fractures of the femur and bisphosphonate therapy A systematic review of case/case series studies
    Giusti, Andrea
    Hamdy, Neveen A. T.
    Papapoulos, Socrates E.
    BONE, 2010, 47 (02) : 169 - 180
  • [50] Atraumatic Bilateral Femur Fracture in Long-Term Bisphosphonate Use
    Ott, Susan M.
    ORTHOPEDICS, 2010, 33 (07) : 468 - 468